Validation of a Questionnaire to Measure Cough Severity
Launched by FUNDACIÓ INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU · Oct 31, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating and testing a new questionnaire designed to measure the severity of chronic cough. Chronic cough is a persistent cough that can be bothersome and affect daily life. The goal of the study is to develop a tool that provides an objective way to assess how severe this cough is, which can help doctors better understand and treat patients with this condition.
To participate in the trial, individuals must be between the ages of 30 and 99 and either have a clinical diagnosis of chronic cough or be healthy volunteers. Participants should also be comfortable speaking and understanding Spanish. Those who are unable to fill out the questionnaires or do not sign the consent form will not be eligible. If you join the study, you can expect to complete some questionnaires that will help researchers gather important information about your cough. The trial is currently not recruiting participants, but it aims to improve the way cough severity is measured in future treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged between 30 and 99 years
- • Clinical diagnosis of chronic cough or healthy volunteers
- • Good understanding of Spanish
- Exclusion Criteria:
- • Non-Spanish-speaking patients
- • Inability to complete the questionnaires
- • Failure to sign the informed consent form
About Fundació Institut De Recerca De L'hospital De La Santa Creu I Sant Pau
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau is a leading biomedical research organization based in Barcelona, dedicated to advancing scientific knowledge and improving patient care. Affiliated with the prestigious Hospital de la Santa Creu i Sant Pau, the foundation focuses on translational research across various medical disciplines, fostering innovation through collaboration among researchers, clinicians, and industry partners. It aims to bridge the gap between laboratory discoveries and clinical applications, ultimately enhancing healthcare outcomes and contributing to the global understanding of diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Trial Officials
Astrid Crespo-Lessmann, PhD
Principal Investigator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported